Abstract
Many patients with cancer may have concomitant opioid use disorder (OUD) or non-medical opioid use (NMOU). Though the prevalence is not well characterized, patients with lung cancer may have higher prevalence of OUD related to known relationships with other substance use disorders including alcohol and tobacco. However, little is known about optimal ways to manage pain and reduce the risk of harm for these patients. Single center studies suggest multidisciplinary management may improve care though the optimal implementation and feasibility of this management is unknown.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
